Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

224
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
224
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

208
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
208
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

246
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
246
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

644
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
644
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

198
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
198
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

189
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
189

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Uptake of Colorectal Cancer Screening by Physicians Is Associated With Greater Uptake by Their Patients.

Gastroenterology·2019
Same author

Preoperative Vitamin D Concentration and Cardiac, Renal, and Infectious Morbidity after Noncardiac Surgery.

Anesthesiology·2019
Same author

Identifying Ontario geographic regions to assess adults who present to hospital with laboratory-defined conditions: a descriptive study.

CMAJ open·2019
Same author

Home Dialysis Is Associated with Lower Costs and Better Survival than Other Modalities: A Population-Based Study in Ontario, Canada.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2019
Same author

Postdonation eGFR and New-Onset Antihypertensive Medication Use After Living Kidney Donation.

Transplantation direct·2019
Same author

Can Split Renal Volume Assessment by Computed Tomography Replace Nuclear Split Renal Function in Living Kidney Donor Evaluations? A Systematic Review and Meta-Analysis.

Canadian journal of kidney health and disease·2019

Related Experiment Video

Updated: Dec 17, 2025

Murine Renal Transplantation Procedure
18:48

Murine Renal Transplantation Procedure

Published on: July 10, 2009

30.4K

Changes in kidney function follow living donor nephrectomy.

Ngan N Lam1, Anita Lloyd2, Krista L Lentine3

  • 1Department of Medicine, Division of Nephrology, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.

Kidney International
|June 24, 2020
PubMed
Summary
This summary is machine-generated.

Living kidney donors show improved kidney function post-donation due to hyperfiltration, unlike healthy non-donors who experience age-related decline. This study tracked kidney function changes over 15 years.

Keywords:
albuminuriacreatinineestimated glomerular filtration rateliving kidney donors

More Related Videos

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.3K
Normothermic Ex Vivo Kidney Perfusion for the Preservation of Kidney Grafts prior to Transplantation
08:12

Normothermic Ex Vivo Kidney Perfusion for the Preservation of Kidney Grafts prior to Transplantation

Published on: July 15, 2015

19.7K

Related Experiment Videos

Last Updated: Dec 17, 2025

Murine Renal Transplantation Procedure
18:48

Murine Renal Transplantation Procedure

Published on: July 10, 2009

30.4K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.3K
Normothermic Ex Vivo Kidney Perfusion for the Preservation of Kidney Grafts prior to Transplantation
08:12

Normothermic Ex Vivo Kidney Perfusion for the Preservation of Kidney Grafts prior to Transplantation

Published on: July 15, 2015

19.7K

Area of Science:

  • Nephrology
  • Transplantation immunology
  • Public health

Background:

  • Understanding long-term kidney function in living kidney donors is crucial for donor selection and care.
  • Donor characteristics may influence post-nephrectomy renal outcomes.
  • Comparative data between living donors and healthy non-donors is limited.

Purpose of the Study:

  • To evaluate kidney function changes after living donor nephrectomy.
  • To compare the trajectory of estimated glomerular filtration rate (eGFR) in living kidney donors versus matched healthy non-donors.
  • To identify potential differences in kidney function based on donor characteristics.

Main Methods:

  • Retrospective matched cohort study using linked healthcare administrative databases in Alberta, Canada (2002-2016).
  • 604 living kidney donors were matched to 2,414 healthy non-donors based on age, sex, year of cohort entry, urban residence, and baseline eGFR.
  • Primary outcome: rate of eGFR change over time, with a median follow-up of seven years (maximum 15 years).

Main Results:

  • Living kidney donors experienced an initial increase in eGFR (+0.35 mL/min/1.73 m²/year) post-donation, attributed to glomerular hyperfiltration.
  • Matched healthy non-donors showed a significant age-related decline in eGFR (-0.85 mL/min/1.73 m²/year).
  • Donor eGFR changes included +1.06 mL/min/1.73 m²/year (6 weeks-2 years), +0.64 mL/min/1.73 m²/year (2-5 years), and -0.06 mL/min/1.73 m²/year (>5 years), indicating a plateau after five years.

Conclusions:

  • Living kidney donation leads to a distinct pattern of kidney function change compared to healthy non-donors.
  • Post-donation hyperfiltration initially enhances kidney function, which then stabilizes.
  • Findings support informed donor selection and follow-up care strategies.